Produkty 984-46-3

CAS 984-46-3 występuje w naszej ofercie pod nazwami: Medroxyprogesterone Acetate Impurity 1, Medroxyprogesterone Acetate EP Impurity A, 6α-Hydroxymedroxyprogesterone Acetate. Oferty producentów: Chemat Brand, Mikromol. Dostępne opakowania: on request, 25mg.

Medroxyprogesterone Acetate Impurity 1
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Medroxyprogesterone Acetate EP Impurity A
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
6α-Hydroxymedroxyprogesterone Acetate
Mikromol
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate (CAS 984-46-3) to związek chemiczny o wzorze sumarycznym C24H34O5 i masie molowej 402.5 g/mol. Nazwa systematyczna IUPAC: [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate. InChIKey: BIIFPBLHBAQCTJ-NHYVCAMTSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H34O5
Masa molowa402.5 g/mol
Nazwa IUPAC[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
InChIKeyBIIFPBLHBAQCTJ-NHYVCAMTSA-N
SMILESCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@](C4=CC(=O)CC[C@]34C)(C)O)C)OC(=O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 6-Hmap, 6-Hydroxy-6-methyl-17-acetoxyprogesterone, Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-hydroxy-6-methyl-, (6alpha)-, 6-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate, 6a-Hydroxy Medroxy Progesterone 17-Acetate, 6alpha-Hydroxymedroxyprogesterone Acetate, 6alpha-Hydroxy Medroxy Progesterone 17-Acetate
Powiązane formy tego związku
[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C24H34O5
Izomery (ten sam wzór sumaryczny)
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid C24H34O5
[(1R,6S,8R,9S,10R,13S,14S,17R)-17-acetyl-1-hydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O5
methyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoate C24H34O5
[(2S,6S,8R,9S,10R,13S,14S,17R)-17-acetyl-2-hydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O5
[(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate C24H34O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate C24H34O5
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate C24H34O5
(13S,17R)-13-methyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-ol C24H34O5
(8S,13S,14S,17S)-13-methyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-ol C24H34O5
[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-3-methylidene-2,7,8,8a-tetrahydro-1H-naphthalen-1-yl] (2S)-2-methylbutanoate C24H34O5
(4R,6'R,8'R,9'S,10'R,13'S,14'S)-6'-hydroxy-2,2,10',13'-tetramethylspiro[1,3-dioxane-4,17'-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-3',5-dione C24H34O5